hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 7.50
+0.15 (2.04%)
May 6, 2026, 5:08 PM GMT
hVIVO Market Cap
hVIVO has a market cap or net worth of 50.5 million as of May 6, 2026. Its market cap has decreased by -54.61% in one year.
Market Cap
50.50M
Enterprise Value
50.99M
Revenue
49.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.50
Market Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 50.50M, an increase of 192.94%. That is a compound annual growth rate of 16.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 50.50M | 17.81% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 88.82M |
| Faron Pharmaceuticals Oy | 82.80M |
| 4basebio | 78.16M |
| Ondine Biomedical | 62.35M |
| Hemogenyx Pharmaceuticals | 43.69M |
| Poolbeg Pharma | 31.73M |
| Sareum Holdings | 27.96M |
| SkinBioTherapeutics | 25.27M |